Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
The Science Business
Org Prep Daily
Kilomentor
On Pharma
Kinase Pro
Pharma Conduct
Chemical Quantum Images
The LouRoe
One in Ten Thousand
Intermolecular
Periodic Tabloid
Chemical Musings
C&E News Blog
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Chirality
Mad Chemist Chick
BBSRC/Douglas Kell
Drug Discovery Opinion
The Chemblog
Realizations in Biostatistics
Molecule of the Day
Chemjobber
Pharmalot
WSJ Health Blog
Chemical Crystallinity
ChemSpider Blog
Pharmagossip
Med-Chemist
Organometallic Current
Useful Chemistry
Chiral Jones
Great Molecular Crapshoot
No Name No Slogan
SimBioSys
Culture of Chemistry
The Curious Wavefunction
Chemical Sabbatical
Natural Product Man
Totally Synthetic
Zusammen
My Chemical Journey
The F- Blog
Generally Chemistry
Chemistry World Blog
Synthetic Nature
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
P212121
Curly Arrow
ChemCafe
Power of Goo
Fetz the Chemist
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa
Pharma Blog Review


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Life of a Lab Rat
Nobel Intent
SciTech Daily
Is This Thing On?
Science Blog
Eastern Blot
FuturePundit
Flags and Lollipops
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Terra Sigillata
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Living the Scientific Life
Humans in Science
Speculist
Science, Shrimp and Grits
Cosmic Variance
The Capsule
Zeroth Order Approximation
Science Library Blog
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Hexacyclinol: A Forensic Case | Main | Genentech's Culture: At Risk or Not? »

February 20, 2009

Hexacyclinol - Another Requestr

Email This Entry

Posted by Derek

I'm taking the day off from cranking out the medicines of tomorrow (OK, the day after tomorrow), so there will be no post today.

I did want to add something about yesterday's post on the La Clair/hexacyclinol controversy. I'd like to ask that people not fill up the comments with ad hominem remarks or potentially libelous statements about La Clair himself. I don't mind saying that the evidence so far makes it very hard for me to believe his original paper, and I also have to say that I haven't seen any convincing explanations for all the discrepancies that have turned up. And I think that those opinions are shared by many people who've followed the story.

But let's keep it on a scientific plane, if possible. Opinions on NMR spectra and the like are one thing, but personal insults are another, and those we don't need. I try not to have to go in and hose out the comments sections around here.

Comments (8) + TrackBacks (0) | Category: Blog Housekeeping | Chemical News | The Scientific Literature


COMMENTS

1. Hap on February 20, 2009 1:19 PM writes...

Sorry if I said anything bad (well, the goalposts comment was catty). I don't wish Dr. La Clair any ill, but it would be nice to have a complete picture of the whole hexacyclinol shebang.

Permalink to Comment

2. HOMO-LUMO on February 20, 2009 1:43 PM writes...

To me the point is how an article without any supporting information and with notorious mistakes and irregularities got in Angewandte Chemie.Usually referees ask for lots of stuff before accepting a good paper with isolated and punctual mistakes. Another issue is why some people does not need to comply with rules applicable to almost everybody.

My earlier point is that without controversy the system would not be corrected.

Permalink to Comment

3. Anonymous on February 22, 2009 9:16 AM writes...

HOMO-LUMO: I hope you are kidding. ACIE, along with JACS and other journals, are full of papers with incomplete data for key compounds, including target molecules of natural product syntheses. After years in the field, it is clear to me that there is no real honor for being in one of these "high impact" journals. It rather implies that you know someone on the editorial board or have suggested a very, very friendly (read: they are your friends) set of reviewers. Sadly, the literature has degenerated to this state, with the funding agencies are blindly following the same folly.

Permalink to Comment

4. HOMO-LUMO on February 22, 2009 1:45 PM writes...

Exactly, that´s why controversial cases are good to show how the system is far from perfect and needs fixing.

Always there is an honour in been in that high impact journals if your science is relevant, influential and reproducible.

Permalink to Comment

5. Mad Chemist Chick on February 22, 2009 1:46 PM writes...

I find it very frustrating that you can pull 10 references for procedures and you are lucky if 2 work as described.

For the older literature, this doesn't seem to be a problem. Give me a procedure from a 1940s JACS any day over a 2008 JACS.

Permalink to Comment

6. Anonymous on February 22, 2009 2:13 PM writes...

I will say that J.Org.Chem., and Org.Lett, are now very fastidious about requiring complete compound characterizations in the Supp Info. This makes me more confident that the syntheses described will be succesful. You may not get the same yield, perhaps, but at least you will get product.

Permalink to Comment

7. HOMO-LUMO on February 22, 2009 4:45 PM writes...

Tetrahedron till the 90s is also quite good. In my little experience 8-9 out of ten preps works.

Chemistry before the 70s was a craftmen job, without the comprehensive analysis techniques exiting nowadays is amazing how so many things were discovered and developed. I guess that is one reason why reproducibility was at that time at the top of the academics priorities when publishing a paper.

Permalink to Comment

8. Bill on February 22, 2009 10:24 PM writes...

HOMO-LUMO has hit upon a key point. In the past, most of the top organic chemists were focused on structure elucidation of natural products. This required a wide variety of highly developed lab skills with success still not guaranteed. A good
example was the German chemist (Loucks?) who spent
over 40 years working on the structure of strychnine, only to be 'scooped' by R. B. Woodward. Now modern NMR methods using state-of-the-art equipment could determine the structure of strychnine in, at most a weekend, using no more than 1 mg of sample. In fact, as an NMR spectroscopist, I have been accused by senior organic friends as being one of the ones who
ruined the natural product area by making it too easy. While there is an element of truth in this, nevertheless, one type of skill set has been replaced by another. Modern spectroscopic methods, incorrectly applied, can still give wrong structures. I believe that hexacyclinol is an example where inadequately resolved 2D spectra gave ambiguous results which the original authors interpreted incorrectly, yielding the wrong structure. This is not uncommon, as evidenced by a 2005 article by K.. Nicolau which listed well over 100 structures where spectroscopic methods gave wrong stuctures, mostly I suspect because
authors convinced themselves that their spectra fit their prefered structure, rather than letting
the data lead them to the structure. Overall, I believe that authors, reviewers and editors are all too willing to accept limited data as proving structures, which may at least in part for literature synthetic methods which don't work in
other hands. Certainly. there is a pressing need for editors to insist on detailed procedures and
actual spectra (if only as supplemental material) so that literature reports are reliable and can be reproduced.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Genentech's Culture: At Risk or Not?
Hexacyclinol - Another Requestr
Hexacyclinol: A Forensic Case
Business Books: The Enantiomers
Supplies of Suppliers
Heavy Atoms, Heavy Profits?
Day Off
A Cure for the Common Cold? Don't. . .Ah, Hold Your Breath